文献速递复苏、休克与脓毒症创伤与烧伤

储存低滴度O型全血联合成分输血与单纯成分输血对平民创伤患者的初步研究

A pilot study of stored low titer group O whole blood + component therapy versus component therapy only for civilian trauma patients.
PubMed 文献 · J Trauma Acute Care Surg · 2021-01-01
一句话结论在平民一级创伤中心,以LTOWB启动复苏与单纯成分输血相比,24小时总输血量校正后无差异,结局相当。

本研究为单中心前瞻性队列初步研究,在大型城市一级创伤中心实践变更期间,比较男性创伤患者接受最多4单位冷储存低抗A、抗B O型全血后按需成分输血(LTOWB+CT)与LTOWB不可用时仅接受成分输血(CT,含女性及男性)的差异。主要终点24小时总输血量:未校正中位数LTOWB+CT组2,138 mL vs CT组4,225 mL(p=0.06);校正ISS、性别和FAST阳性后分别为3,307 mL vs 3,260 mL(p=0.95)。校正后血浆/红细胞比值LTOWB+CT组更高(0.85 vs 0.63,p=0.043);校正死亡率4.4% vs 11.7%(p=0.19),并发症及ICU/住院无天数相似。结论为LTOWB启动复苏与单纯成分输血结局相当。

要点

  • 校正ISS、性别和FAST阳性后,LTOWB+CT组24小时输血量3,307 mL vs CT组3,260 mL(p=0.95),无显著差异。
  • 未校正分析中LTOWB+CT组24小时总输血量中位数2,138 mL,低于CT组的4,225 mL,但p=0.06未达统计学显著。
  • 校正后LTOWB+CT组血浆/红细胞比值更高(0.85 vs 0.63,p=0.043),提示更平衡的复苏。
  • 校正死亡率LTOWB+CT组4.4% vs CT组11.7%(p=0.19),并发症及ICU/住院无天数相似。
  • LTOWB组中位输注2.0单位(IQR 1.0-3.0),最多4单位,作为初始复苏后按需成分输血。

适用人群与场景

  • 成人男性创伤患者接受LTOWB+CT;对照组为LTOWB不可用时就诊的女性及男性创伤患者,仅接受CT。
  • 排除标准包括使用抗血小板或抗凝药物以及24小时内死亡。
  • 单中心、大型城市一级创伤中心,急诊创伤复苏场景。

诊断标准与关键阈值

  • 原文未提及

处置流程与药物剂量

  • LTOWB+CT组:初始复苏给予最多4单位冷储存低抗A、抗B O型全血(LTOWB),随后按需给予标准成分输血(CT)。
  • CT组:仅接受标准成分输血。
  • LTOWB组实际输注中位数为2.0单位(IQR 1.0-3.0)。

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 单中心前瞻性队列初步研究,38例接受LTOWB+CT,32例接受CT。
  • 主要终点24小时总输血量:未校正中位数LTOWB+CT组2,138 mL(IQR 1,275-3,325) vs CT组4,225 mL(IQR 1,900-5,425),p=0.06。
  • 校正ISS、性别和FAST阳性后,24小时输血量LTOWB+CT组3,307 mL vs CT组3,260 mL,p=0.95。
  • 校正后血浆/红细胞比值LTOWB+CT组0.85 vs CT组0.63,p=0.043。
  • 校正死亡率LTOWB+CT组4.4% vs CT组11.7%,p=0.19;并发症及ICU/住院无天数相似。

证据类型、等级与局限

  • 证据类型:单中心前瞻性队列初步研究(pilot study)。
  • 证据等级:治疗性研究,level III(前瞻性研究,1项阴性标准,混杂因素控制有限)。

对床旁实践的改变

  • 对于平民创伤患者,以LTOWB启动复苏后按需成分输血,与单纯成分输血相比校正后24小时总输血量无差异,死亡率和并发症相似,不支持常规以LTOWB替代成分输血来减少总输血量。
  • LTOWB+CT可提高校正后血浆/红细胞比值(0.85 vs 0.63),但本研究未显示临床结局获益。
  • 本研究排除了使用抗血小板或抗凝药物者及24小时内死亡者,结果不适用于这些人群;单中心小样本非随机设计,结论需前瞻性随机研究验证。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: This pilot assessed transfusion requirements during resuscitation with whole blood followed by standard component therapy (CT) versus CT alone, during a change in practice at a large urban Level I trauma center.

METHODS: This was a single-center prospective cohort pilot study. Male trauma patients received up to 4 units of cold-stored low anti-A, anti-B group O whole blood (LTOWB) as initial resuscitation followed by CT as needed (LTOWB + CT). A control group consisting of women and men who presented when LTOWB was unavailable, received CT only (CT group). Exclusion criteria included antiplatelet or anticoagulant medication and death within 24 hours. The primary outcome was total transfusion volume at 24 hours. Secondary outcomes were mortality, morbidity, and intensive care unit- and hospital-free days.

RESULTS: Thirty-eight patients received LTOWB, with a median of 2.0 (interquartile range [IQR] 1.0-3.0) units of LTOWB transfused. Thirty-two patients received CT only. At 24 hours after presentation, the LTOWB +CT group had received a median of 2,138 mL (IQR, 1,275-3,325 mL) of all blood products. The median for the CT group was 4,225 mL (IQR, 1,900-5,425 mL; p = 0.06) in unadjusted analysis. When adjusted for Injury Severity Score, sex, and positive Focused Assessment with Sonography for Trauma, LTOWB +CT group patients received 3307 mL of blood products, and CT group patients received 3,260 mL in the first 24 hours (p = 0.95). The adjusted median ratio of plasma to red cells transfused was higher in the LTOWB + CT group (0.85 vs. 0.63 at 24 hours after admission; p = 0.043. Adjusted mortality was 4.4% in the LTOWB + CT group, and 11.7% in the CT group (p = 0.19), with similar complications, intensive care unit-, and hospital-free days in both groups.

CONCLUSION: Beginning resuscitation with LTOWB results in equivalent outcomes compared with resuscitation with CT only.

LEVEL OF EVIDENCE: Therapeutic (Prospective study with 1 negative criterion, limited control of confounding factors), level III.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Siletz AE, Blair KJ, Cooper RJ, et al. A pilot study of stored low titer group O whole blood + component therapy versus component therapy only for civilian trauma patients. J Trauma Acute Care Surg. 2021. PMID: 34225348. doi:10.1097/TA.0000000000003334

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。